Driehaus Capital Management LLC Pfizer Inc Transaction History

Driehaus Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $11.6 Million - $13.7 Million	248,396 Added 20.91%	1,436,482 $75.3 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $54.2 Million - $67.1 Million	1,183,819 Added 27743.59%	1,188,086 $61.5 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $176,312 - $261,353	4,267 New	4,267 $252,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $452,975 - $587,376	-13,942 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $515,575 - $578,871	13,942 New	13,942 $604,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $303,600 - $333,555	-8,096 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $3,770 - $4,298	-98 Reduced 1.2%	8,096 $353,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $14,546 - $17,643	422 Added 5.43%	8,194 $361,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $131,491 - $140,182	-3,987 Reduced 33.91%	7,772 $282,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $8,424 - $9,773	264 Added 2.3%	11,759 $417,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $356,345 - $392,554	11,495	11,495 $410,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.